Both CXCR4 and ACKR3 signaling pathways promote tumor growth and metastasis in breast cancer and multiple other malignancies, making these receptors potential targets for therapy and molecular imaging [12,13,14,15]. This evidence concerns the gene CXCR4 and breast carcinoma.